Top 5 Health Care Companies and Stocks in Malaysia 2024

Globally, the healthcare industry has long been a rapidly growing and crucial sector. Particularly in Malaysia, with the aging population, heightened health awareness, and the rapid advancement of medical technology, the industry is on the cusp of unprecedented opportunities for growth and development.

This article delves into the leading enterprises within Malaysia’s healthcare sector, particularly focusing on those that are prominent in the Malaysia share market, particularly those listed on Bursa Malaysia, analyzing the potential for stock investment.

Why Invest in Malaysian Health Care Companies?

Growing Market Potential

Malaysia’s healthcare sector is experiencing rapid growth, with healthcare expenditure increasing at a rate higher than the country’s economic growth. It is projected that personal healthcare spending in Malaysia will double to $2.8 billion by 2028. One key factor contributing to this growth is the aging population, with 10% of Malaysians now over the age of 60. This demographic shift is resulting in a higher demand for geriatric care, leading to a growing market for elderly care services and products that cater to the unique needs of this segment.

These factors present a compelling case for investors to consider the Malaysia share market, particularly for health care products company and home care companies, as they offer ample opportunities for those prepared to address the evolving healthcare landscape.

Government Support

The Malaysian government’s dedication to the healthcare sector, including support for health care products company and home health care companies, as well as other healthcare initiatives, is evident through its escalated financial investment and strategic policy implementations aimed at enhancing medical infrastructure and service quality. The substantial increase in the Ministry of Health’s budget, which jumped to $7.9 billion in 2023 from $7.1 billion in 2022, underscores the nation’s commitment to public health services. This not only assures better healthcare delivery but also fosters a nurturing environment for the growth of healthcare businesses. In addition to this, the government offers tax incentives and other supportive measures to entice further investment in the healthcare sector. These proactive steps by the government create a compelling investment climate, making Malaysian healthcare companies an attractive proposition for investors seeking a robust and supportive market.

Medical Tourism

Malaysia is rapidly emerging as a prime destination for medical tourism, offering international patients a compelling combination of high-value medical services and significantly reduced waiting times compared to many Western countries. The government’s strategic implementation of visa-free policies for certain countries has further fueled the growth of this sector, making Malaysia an even more attractive proposition for those seeking quality healthcare abroad.

Moreover, with the Malaysian government actively promoting the nation as a regional hub for specialized treatments in fertility, cardiology, and cancer care, the market for medical tourism is experiencing a robust expansion. This targeted approach not only benefits patients from around the world who are in need of these specific services but also opens up a wealth of opportunities for investors looking to capitalize on the burgeoning demand for advanced medical care.

The convergence of these factors positions Malaysia as a leader in medical tourism, providing a unique value proposition that is both a draw for international patients as well as a catalyst for investment in the healthcare sector.

Manufacturing Strength

Malaysia's prowess in the healthcare industry extends beyond its services to the manufacturing of medical consumables, particularly rubber-based products. The country has established itself as a dominant force in the global market for rubber medical consumables, with an emphasis on the production of rubber gloves and catheters. This manufacturing strength is a testament to the high international quality standards upheld by local manufacturers, which not only meet but often exceed the expectations of the global healthcare market.

The local manufacturers' commitment to quality and innovation has endowed them with a strong international competitiveness, making Malaysian-made healthcare products sought after in the global arena. This competitive edge, coupled with the country's strategic focus on the healthcare sector, positions Malaysia as an attractive hub for investment in the manufacturing of medical consumables, offering investors a gateway to a robust and expanding market.

6 Important Factors that Affect Malaysian Health Care Industry

1. Government Policies and Initiatives: The Malaysian government plays a pivotal role in shaping the healthcare industry through policy-making and funding. National health initiatives, budget allocations to the Ministry of Health, and the implementation of strategic plans like the Health White Paper's ICT Masterplan significantly influence the development and growth of the sector, including the performance of home health care companies on the Malaysia share market.

2. Demographic Trends: Malaysia's aging population and the rise in non-communicable diseases are driving factors for the healthcare industry. An increased elderly population necessitates a greater demand for specialized care and services, leading to potential growth in geriatric healthcare services and products.

3. Advancements in Medical Technology: Rapid advancements in technology are revolutionizing the healthcare sector. Telemedicine, electronic health records, and the integration of AI and big data in diagnostics and patient care are not only improving service delivery but also creating new opportunities for tech-savvy healthcare companies.

4. Healthcare Infrastructure Development: Investments in healthcare infrastructure, such as new hospitals, clinics, and advanced medical facilities, particularly in rural and remote areas, are critical for enhancing accessibility and quality of care. The government and private sector's commitment to infrastructure development can significantly impact the industry's trajectory.

5. Workforce Development and Training: The availability of a skilled workforce is essential for the healthcare industry. Medical professionals, including doctors, nurses, and allied health professionals, need continuous training and development to keep up with medical advancements and to meet the growing demand for healthcare services.

6. Public-Private Partnerships (PPPs): PPPs are crucial in expanding the reach and quality of healthcare services. Collaborations between public and private entities can lead to innovative solutions, improved efficiency, and better patient outcomes. The Malaysian government's openness to PPPs in healthcare is a significant factor that can attract further investment and development in the sector.

Top 5 Malaysian Health Care Companies and Stocks

You can take a look at the in-depth descriptions of five selected Malaysian healthcare sector stocks below.

IHH Healthcare Bhd(5225)

IHH Healthcare Bhd, a global healthcare provider headquartered in Malaysia and listed on the Malaysia share market, operates a comprehensive network of health clinics, hospitals, and post-operative rehabilitation centers worldwide. The company extends its services to include a range of auxiliary services such as diagnostic laboratories, imaging centers, non-hospital care, and medical education facilities.

The primary revenue stream for IHH Healthcare Bhd comes from its Parkway Pantai division in Asia, which holds a significant position in hospital operations and medical services in Singapore and Malaysia. The second major source of income is Acibadem Holding Group, a hospital operator and service provider active in Central Europe, Eastern Europe, the Middle East, and North Africa.

The business of IHH Healthcare Bhd spans across various countries and regions, including Singapore, Malaysia, India, Greater China, Turkey, and Europe. The group's operational divisions are further diversified into IMU Health and PLife REIT, showcasing the company's extensive reach and depth in different healthcare sectors.

Recent Financial Performance： For the first quarter of 2024, IHH Healthcare Bhd saw a 45% drop in net profit to RM767.97 million, due to the lack of asset disposal gains compared to the previous year. Revenue rose by 16% to a record RM5.96 billion, supported by increased demand and price adjustments. Core earnings, excluding one-off items, grew by 22.1%.Despite challenges from inflation and operational costs, the company is confident in its strategic growth plans and closed at a valuation of RM54.52 billion.

Top Glove(7113)

Top Glove Corporation Bhd, stands as a Malaysian-based global leader in the manufacturing and distribution of a diverse range of disposable gloves. With a robust product portfolio that includes latex, nitrile, vinyl, PE, polyhydroxybutyrate, isopren gloves, Flexylon, high-density polyethylene gloves, and surgical gloves, Top Glove caters to a multitude of sectors such as aerospace, food, personal care, healthcare, dental care, and household care. The company's traditional sales strength lies in its nitrile and latex powdered production lines, which have historically accounted for more than half of its sales, reflecting a significant market presence. Top Glove's clientele is notably strong in North America and Europe, indicating a well-established global footprint. Renowned for its quality and innovation, Top Glove continues to be a preferred choice for customers seeking reliable and high-standard protective solutions.

Recent Financial Performance： In the third quarter of 2024, Top Glove Corporation Bhd rebounded to a net profit of RM50.67 million, reversing a loss of RM130.59 million from the same period last year. Earnings per share turned positive to 0.63 sen, up from a loss of 1.63 sen. Revenue for the quarter rose to RM636.88 million, an increase from RM530.62 million. Despite a net loss of RM58.24 million over nine months, the company's performance significantly improved from the previous year's loss of RM463.49 million. The recovery was driven by increased glove demand and strategic cost management that offset higher raw material expenses.

Kpj Healthcare Bhd(5878)

KPJ Healthcare Bhd is a prominent healthcare services provider with a stronghold in the Asia-Pacific region. Operating primarily in Malaysia's private healthcare sector, KPJ generates nearly all of its revenue domestically. The company's extensive healthcare operations encompass hospital management, development of new hospitals, clinical services, outpatient care, ancillary services, diagnostic services, and specialized care for the elderly and assisted living. Demonstrating its regional influence, KPJ extends its medical solutions and treatments to countries including Indonesia, Thailand, Bangladesh, and Australia. With a commitment to clinical excellence and innovation, KPJ Healthcare Bhd has established itself as a leader in delivering comprehensive healthcare services, reflecting its expertise in both conventional and modern medical practices.

Recent Financial Performance： KPJ Healthcare Bhd reported a significant 38.9% year-on-year increase in net profit for the first quarter ending March 31, 2024 (1QFY2024), reaching RM71.40 million, up from RM51.39 million in the same period last year. This growth was primarily due to an increase in patient numbers and the sale of its Australian aged care business, which improved the company's financial position by eliminating net liabilities of RM43.3 million. Revenue for the quarter also increased by 11.4% to RM908.02 million, driven by a 3.4% rise in patient numbers. Additionally, the group expanded its bed capacity to 3,693 beds, resulting in a slight decrease in bed occupancy to 65%.

Kossan Rubber Industries Bhd(7153)

Kossan Rubber Industries Bhd is a leading Malaysian company that specializes in manufacturing industrial rubber products and single-use latex gloves. The company's expertise spans three main business areas: cleanroom products, gloves, and technical rubber products. Gloves are the largest contributor to sales. Kossan is renowned for its production of gloves, latex thread, latex foam, and other related products. Its diverse range of products are utilized in various industries including healthcare, automotive, and consumer goods.

Recent Financial Performance： For 1QFY2024, Kossan Rubber Industries Bhd achieved a net profit of RM31.45 million, a significant improvement from the RM24.25 million net loss in the previous year's quarter. This result was driven by increased sales and lower natural gas prices, with revenue growing 14.4% to RM451.63 million. Despite industry challenges, the glove division made a strong recovery, and the technical rubber products division saw a 12.7% increase in profit before tax.

Supermax Corp Bhd(7106)

Supermax Corp Bhd is a renowned investment holding company specializing in the manufacturing, distribution, and sale of high-quality medical gloves and contact lenses. With a global reach, Supermax exports its latex gloves to over 155 countries, establishing its presence across the US, Europe, and Asia. The company's operations are segmented into investment holding, glove manufacturing, and glove trading, with a significant revenue contribution from the trading sector. Supermax's largest market, in terms of revenue, is located in North, Central, and South America. The company's focus on quality and international distribution has solidified its position as a leading manufacturer and distributor in the medical gloves industry.

Recent Financial Performance： For the third quarter ending March 31, 2024 (3QFY2024), Supermax Corp Bhd narrowed its net loss to RM686,000 from a previous loss of RM39.92 million in 3QFY2023, achieving a slight profit margin of 0.1%. This improvement, despite a decline in quarterly revenue by 18.63% to RM143.01 million, was due to better cost management and operational efficiency. The reduction in net loss reflects the company's efforts to streamline production lines and optimize costs. However, the overall market demand for gloves remained weak as customers continued to destock from pandemic-induced surpluses.

Conclusion

In conclusion, the Malaysian healthcare sector is a vibrant and dynamic industry that offers a wealth of opportunities for investors. With strong government backing and a growing market driven by an aging population and health tourism, Malaysia is positioning itself as a strategic hub for healthcare services and products. The robust manufacturing base for medical consumables, including health care products company and home health care companies, further enhances this strategic positioning.

The top healthcare companies in the Malaysia share market, including IHH Healthcare Bhd, Top Glove Corporation Bhd, KPJ Healthcare Bhd, Kossan Rubber Industries Bhd, and Supermax Corp Bhd, have shown resilience and growth potential, highlighting the strength and diversity of the industry. They provide a broad range of investment opportunities within the thriving healthcare landscape of Malaysia. However, as with all investments, the sector comes with inherent risks and market fluctuations. Investors should conduct diligent research, understand their risk tolerance, and consider a diversified portfolio with a long-term perspective to navigate the dynamic and evolving healthcare market effectively.